PUBLIC CONTRACT · 2024
Aquisição de Risancizumab 150 mg/ml 1 ml caneta pré cheia SC - CPA 491/2023
- Contract value
- €223,757.30
- Signed on
- 2 August 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10852001PUBLISHED SUBJECT
Aquisição de Risancizumab 150 mg/ml 1 ml caneta pré cheia SC - CPA 491/2023
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Viana do Castelo, Viana do Castelo
- NUTS region
- PT111 - Alto Minho
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Abbvie, Lda · Tax ID 510229050
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €223,757.30
- Procedure base price
- €223,757.30
- Total effective price
- Not reported on Portal BASE
- Publication date
- 2 August 2024
- Award date
- 1 August 2024
- Signing date
- 2 August 2024
- Performance period
- 153 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 26.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7159900
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.